BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17124250)

  • 21. Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement.
    Noss EH; Chang SK; Watts GF; Brenner MB
    Arthritis Rheum; 2011 Dec; 63(12):3768-78. PubMed ID: 22127696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
    Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
    Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis.
    Gui H; Liu X; Wang ZW; He DY; Su DF; Dai SM
    Rheumatology (Oxford); 2014 May; 53(5):802-9. PubMed ID: 24440992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts.
    Perlman H; Bradley K; Liu H; Cole S; Shamiyeh E; Smith RC; Walsh K; Fiore S; Koch AE; Firestein GS; Haines GK; Pope RM
    J Immunol; 2003 Jan; 170(2):838-45. PubMed ID: 12517948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.
    Pohlers D; Beyer A; Koczan D; Wilhelm T; Thiesen HJ; Kinne RW
    Arthritis Res Ther; 2007; 9(3):R59. PubMed ID: 17594488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.
    van Lent PL; Span PN; Sloetjes AW; Radstake TR; van Lieshout AW; Heuvel JJ; Sweep CG; van den Berg WB
    Ann Rheum Dis; 2005 Mar; 64(3):368-74. PubMed ID: 15485996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis.
    Xue M; Chan YK; Shen K; Dervish S; March L; Sambrook PN; Jackson CJ
    Arthritis Rheum; 2012 Jan; 64(1):88-98. PubMed ID: 21905006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of α-defensin-1 and related signal transduction mechanisms in the production of IL-6, IL-8 and MMPs in rheumatoid fibroblast-like synoviocytes.
    Ahn JK; Huang B; Bae EK; Park EJ; Hwang JW; Lee J; Koh EM; Cha HS
    Rheumatology (Oxford); 2013 Aug; 52(8):1368-76. PubMed ID: 23620556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections.
    Kanangat S; Postlethwaite A; Hasty K; Kang A; Smeltzer M; Appling W; Schaberg D
    Arthritis Res Ther; 2006; 8(6):R176. PubMed ID: 17129374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritis.
    Bartok B; Boyle DL; Liu Y; Ren P; Ball ST; Bugbee WD; Rommel C; Firestein GS
    Am J Pathol; 2012 May; 180(5):1906-16. PubMed ID: 22433439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2.
    Molloy ES; Morgan MP; Doherty GA; McDonnell B; O'Byrne J; Fitzgerald DJ; McCarthy GM
    Ann Rheum Dis; 2008 Dec; 67(12):1773-9. PubMed ID: 18223264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiopoietin 1 directly induces destruction of the rheumatoid joint by cooperative, but independent, signaling via ERK/MAPK and phosphatidylinositol 3-kinase/Akt.
    Hashiramoto A; Sakai C; Yoshida K; Tsumiyama K; Miura Y; Shiozawa K; Nose M; Komai K; Shiozawa S
    Arthritis Rheum; 2007 Jul; 56(7):2170-9. PubMed ID: 17599743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG; Nowak RA
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of p21-activated kinase 1 in regulating the migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients.
    Fu D; Yang Y; Xiao Y; Lin H; Ye Y; Zhan Z; Liang L; Yang X; Sun L; Xu H
    Rheumatology (Oxford); 2012 Jul; 51(7):1170-80. PubMed ID: 22416254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10.
    Tolboom TC; Pieterman E; van der Laan WH; Toes RE; Huidekoper AL; Nelissen RG; Breedveld FC; Huizinga TW
    Ann Rheum Dis; 2002 Nov; 61(11):975-80. PubMed ID: 12379519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-614 alters the production of matrix metalloproteinases (MMP-1 andMMP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro.
    Du F; Lü LJ; Teng JL; Shen N; Ye P; Bao CD
    Int Immunopharmacol; 2012 May; 13(1):54-60. PubMed ID: 22446297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis.
    Pohlers D; Huber R; Ukena B; Kinne RW
    Arthritis Rheum; 2006 Mar; 54(3):788-94. PubMed ID: 16508943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.
    Burger D; Rezzonico R; Li JM; Modoux C; Pierce RA; Welgus HG; Dayer JM
    Arthritis Rheum; 1998 Oct; 41(10):1748-59. PubMed ID: 9778216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis.
    Tomita T; Nakase T; Kaneko M; Shi K; Takahi K; Ochi T; Yoshikawa H
    Arthritis Rheum; 2002 Feb; 46(2):373-8. PubMed ID: 11840439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.